Yezan Munther Haddadin
Director, Outlook Therapeutics, Inc.
Companies
- Outlook Therapeutics, Inc.Board member Nov 1, 2017 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Outlook Therapeutics, Inc. OTLK66,167 shares2$33.6K at $0.51Jun 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 2, 2026Bought 29,000 shares at $0.83 of Outlook Therapeutics, Inc.2
- May 26, 2026Bought 34,000 shares at $0.44 of Outlook Therapeutics, Inc.3
- Mar 28, 2024Bought 1,882 shares at $11.82 of Outlook Therapeutics, Inc.4
- Oct 7, 2022Bought 3,600 shares at $1.27 of Outlook Therapeutics, Inc.5
- Oct 6, 2022Bought 29,743 shares at $1.29 of Outlook Therapeutics, Inc.5
- Dec 2, 2021Bought 10,000 shares at $1.39 of Outlook Therapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 27, 2026
- 4SEC EDGARForm 4 filed Mar 29, 2024
- 5SEC EDGARForm 4 filed Oct 11, 2022
- 6SEC EDGARForm 4 filed Dec 2, 2021